TrialInternational journal of dermatology2026

Predictors of Efficacy Maintenance After Vunakizumab Discontinuation in Patients With Moderate-to-Severe Plaque Psoriasis: A Post Hoc Analysis of a Randomized Controlled Trial.

Xiaoling Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.